Zurich Cantonal Bank’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,396
| Closed | -$21.7K | – | 2748 |
|
|
2023
Q3 | $21.7K | Hold |
6,396
| – | – | ﹤0.01% | 2702 |
|
|
2023
Q2 | $47K | Hold |
6,396
| – | – | ﹤0.01% | 2632 |
|
|
2023
Q1 | $66.3K | Hold |
6,396
| – | – | ﹤0.01% | 2505 |
|
|
2022
Q4 | $75.5K | Hold |
6,396
| – | – | ﹤0.01% | 2441 |
|
|
2022
Q3 | $134K | Hold |
6,396
| – | – | ﹤0.01% | 1999 |
|
|
2022
Q2 | $199K | Hold |
6,396
| – | – | ﹤0.01% | 1792 |
|
|
2022
Q1 | $263K | Sell |
6,396
-859
| -12% | -$37.9K | ﹤0.01% | 1725 |
|
|
2021
Q4 | $315K | Buy |
7,255
+2,544
| +54% | +$115K | ﹤0.01% | 1783 |
|
|
2021
Q3 | $236K | Hold |
4,711
| – | – | ﹤0.01% | 1804 |
|
|
2021
Q2 | $297K | Hold |
4,711
| – | – | ﹤0.01% | 1553 |
|
|
2021
Q1 | $438K | Sell |
4,711
-870
| -16% | -$89.1K | ﹤0.01% | 1313 |
|
|
2020
Q4 | $500K | Buy |
5,581
+434
| +8% | +$39.8K | ﹤0.01% | 1290 |
|
|
2020
Q3 | $532K | Hold |
5,147
| – | – | ﹤0.01% | 1066 |
|
|
2020
Q2 | $407K | Buy |
5,147
+1,451
| +39% | +$108K | ﹤0.01% | 1111 |
|
|
2020
Q1 | $214K | Buy |
3,696
+808
| +28% | +$46.6K | ﹤0.01% | 1199 |
|
|
2019
Q4 | $156K | Buy |
2,888
+294
| +11% | +$15.9K | ﹤0.01% | 1466 |
|
|
2019
Q3 | $136K | Hold |
2,594
| – | – | ﹤0.01% | 1453 |
|
|
2019
Q2 | $125K | Hold |
2,594
| – | – | ﹤0.01% | 1490 |
|
|
2019
Q1 | $131K | Sell |
2,594
-489
| -16% | -$28.8K | ﹤0.01% | 1416 |
|
|
2018
Q4 | $183K | Buy |
3,083
+847
| +38% | +$54.6K | ﹤0.01% | 1249 |
|
|
2018
Q3 | $147K | Buy |
2,236
+316
| +16% | +$18.4K | ﹤0.01% | 1480 |
|
|
2018
Q2 | $97K | Hold |
1,920
| – | – | ﹤0.01% | 1661 |
|
|
2018
Q1 | $101K | Hold |
1,920
| – | – | ﹤0.01% | 1592 |
|
|
2017
Q4 | $89K | Buy |
1,920
+511
| +36% | +$21.5K | ﹤0.01% | 1637 |
|
|
2017
Q3 | $57K | Buy |
1,409
+391
| +38% | +$14.1K | ﹤0.01% | 1721 |
|
|
2017
Q2 | $35K | Hold |
1,018
| – | – | ﹤0.01% | 1976 |
|
|
2017
Q1 | $30K | Hold |
1,018
| – | – | ﹤0.01% | 2110 |
|
|
2016
Q4 | $33K | Hold |
1,018
| – | – | ﹤0.01% | 1996 |
|
|
2016
Q3 | $32K | Buy |
1,018
+201
| +25% | +$5.84K | ﹤0.01% | 1943 |
|
|
2016
Q2 | $23K | Hold |
817
| – | – | ﹤0.01% | 1983 |
|
|
2016
Q1 | $30K | Hold |
817
| – | – | ﹤0.01% | 1735 |
|
|
2015
Q4 | $33K | Buy |
817
+527
| +182% | +$18.4K | ﹤0.01% | 1696 |
|
|
2015
Q3 | $8K | Hold |
290
| – | – | ﹤0.01% | 2202 |
|
|
2015
Q2 | $10K | Hold |
290
| – | – | ﹤0.01% | 1375 |
|
|
2015
Q1 | $8K | Buy |
+290
| New | +$8.32K | ﹤0.01% | 1500 |
|
Other funds holding EBS
Zurich Cantonal Bank's EBS Position: Q4 2023 in Review
Zurich Cantonal Bank sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 6,396 shares — an estimated $21.7K sold.
Zurich Cantonal Bank first reported a position in EBS in Q1 2015 and held it in 35 quarters. The position peaked at $532K in Q3 2020. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.
- Zurich Cantonal Bank reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
- Zurich Cantonal Bank sold 6,396 Emergent Biosolutions shares in Q4 2023, an estimated $21.7K.
- Zurich Cantonal Bank first reported a position in Emergent Biosolutions in Q1 2015 and held it in 35 quarters.
- Zurich Cantonal Bank's Emergent Biosolutions position peaked at $532K in Q3 2020.
- 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.
Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.